MRVI CIK: 1823239

Maravai LifeSciences Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
659
FY22:
714
FY23:
140
FY24:
108
FY25:
34.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
555
FY22:
574
FY23:
117
FY24:
−84.7
FY25:
−63.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
531
FY22:
551
FY23:
618
FY24:
−261
FY25:
−235
(positive)
Change from FY21 to FY25
millions USD
FY21:
182
FY22:
220
FY23:
−119
FY24:
−145
FY25:
−131

All amounts in millions USD Data source:SEC EDGAR